Monday.com Reports Q4 Results, Joins AN2 TherapeuticsAnd Other Big Stocks Moving Lower In Monday's Pre-Market Session
Portfolio Pulse from Avi Kapoor
In Monday's pre-market trading session, monday.com Ltd. (MNDY) shares fell sharply after reporting Q4 financial results, with adjusted earnings of 65 cents per share on sales of $202.57 million. Other stocks experiencing declines include AN2 Therapeutics, Inc. (ANTX), TELUS International (Cda) Inc. (TIXT), Applied Digital Corporation (APLD), Precigen, Inc. (PGEN), Microvast Holdings, Inc. (MVST), Wynn Resorts, Limited (WYNN), Larimar Therapeutics, Inc. (LRMR), and Manchester United plc (MANU), each for various reasons ranging from disappointing financial results to regulatory updates.
February 12, 2024 | 1:16 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
AN2 Therapeutics shares fell 72% to $5.59 in pre-market trading after announcing a pause in enrollment for a Phase 3 clinical trial.
The significant drop in AN2 Therapeutics' stock price is directly related to the announcement of pausing enrollment in a pivotal clinical trial, which raises concerns about the company's near-term prospects.
CONFIDENCE 90
IMPORTANCE 95
RELEVANCE 100
NEGATIVE IMPACT
Applied Digital Corporation shares dipped 7.5% to $4.88 in pre-market trading after reporting worse-than-expected Q2 financial results last month.
Applied Digital's recent share price drop is likely due to lingering negative sentiment from its worse-than-expected Q2 financial results, impacting investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Larimar Therapeutics shares fell 3.9% to $7.46 in pre-market trading after a 24% surge on Friday.
The decline in Larimar Therapeutics' stock price could be a natural pullback following the previous session's significant gain, indicating short-term market adjustments.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Manchester United plc shares fell 3% to $20.50 in pre-market trading.
Manchester United's pre-market decline may reflect short-term trading dynamics or investor reactions to external factors not detailed in the news.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
monday.com reported Q4 earnings of 65 cents per share on sales of $202.57 million, leading to a 9% drop in pre-market trading.
The sharp decline in monday.com's share price following its Q4 earnings report suggests investor disappointment or concern over the results, likely impacting the stock negatively in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Microvast Holdings shares slipped 5% to $0.96 in pre-market trading after a 9% gain on Friday.
Microvast Holdings' pre-market decline could be a market correction following Friday's gain, reflecting short-term trading volatility.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Precigen shares declined 6.4% to $1.31 in pre-market trading after receiving Orphan Drug designation from the European Commission last month.
Despite the positive regulatory update, Precigen's stock price decline suggests other factors or broader market sentiments may be influencing investor perception negatively.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
TELUS International shares fell 11% to $8.37 in pre-market trading after reporting disappointing fourth-quarter results.
The decline in TELUS International's stock price can be attributed to its disappointing fourth-quarter financial performance, likely leading to negative investor sentiment in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Wynn Resorts shares fell 4.4% to $101.00 in pre-market trading despite reporting better-than-expected fourth-quarter financial results last week.
Wynn Resorts' share price drop, despite positive earnings, suggests that other market factors or broader economic concerns may be at play, affecting investor sentiment.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 100